Markets:

Overview

News

Currencies

International

Treasuries

Pfizer (NY:PFE)

26.65 -0.21 (-0.78%)

Official Closing Price Updated: 7:00 PM EST, Feb 20, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Press Releases about Pfizer

< Previous 1 2 3 4 5 6 7 8 9

...

39 40 Next >

Pfizer’s BRAFTOVI Regimen Improves Progression-Free Survival in Metastatic Colorectal Cancer

February 17, 2026

From Pfizer Inc.

Via Business Wire

FDA Grants Priority Review for HYMPAVZI® (marstacimab) sBLA for the Treatment of Two Hemophilia A or B Patient Populations with Significant Medical Need

February 06, 2026

From Pfizer Inc.

Via Business Wire

Pfizer Launches Cost Savings Program on TrumpRx Lowering Drug Costs for Millions of Americans

February 05, 2026

From Pfizer Inc.

Via Business Wire

Men's Health Network Launches "My Cancer, My Plan" Podcast on World Cancer Day

February 05, 2026

Via PRLog

Topics Death

Rigani Press Announces BioCT's Inaugural Book Event Featuring Dr. S. Yin Ho

February 03, 2026

Via PRLog

Topics Artificial Intelligence

Pfizer Reports Solid Full-Year 2025 Results And Reaffirms 2026 Guidance

February 03, 2026

From Pfizer Inc.

Via Business Wire

Pfizer’s Ultra-Long-Acting Injectable GLP-1 RA Shows Robust and Continued Weight Loss with Monthly Dosing in Phase 2b Trial

February 03, 2026

From Pfizer Inc.

Via Business Wire

Cayenne Wellness Center Celebrates 25 Years of Impact With Star-Studded Fundraising Gala

January 22, 2026

January 22, 2026 -- Supporting Sickle Cell Wellness

Via 24-7 Press Release

Pfizer’s BRAFTOVI® Regimen with Additional Chemotherapy Backbone Increased Response Rates for Certain Patients with Metastatic Colorectal Cancer

January 10, 2026

From Pfizer Inc.

Via Business Wire

Trial Date Has Been Set in MDL against Pfizer for Depo-Provera Overseen by Levin Papantonio

January 07, 2026

From Levin Papantonio

Via Business Wire

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

January 05, 2026

From Pfizer Inc.

Via Business Wire

Pfizer Invites Public to View and Listen to Webcast of February 3 Conference Call with Analysts

December 18, 2025

From Pfizer Inc.

Via Business Wire

Pfizer Reaffirms Full-Year 2025 EPS Guidance and Provides Full-Year 2026 Guidance

December 16, 2025

From Pfizer Inc.

Via Business Wire

Adaptive Biotechnologies Announces Two Immune Receptor Licensing Agreements with Pfizer

December 15, 2025

From Adaptive Biotechnologies

Via GlobeNewswire

Rigani Press Announces Barnes & Noble Book Signing for Dr. S. Yin Ho's Groundbreaking Book

December 12, 2025

Via PRLog

Topics Artificial Intelligence

Pfizer Declares First-Quarter 2026 Dividend

December 12, 2025

From Pfizer Inc.

Via Business Wire

TUKYSA Added to First-Line Maintenance Therapy Extends Median Progression-Free Survival by Over 8 Months in Patients with HER2+ Metastatic Breast Cancer

December 10, 2025

From Pfizer Inc.

Via Business Wire

Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma

December 09, 2025

From Pfizer Inc.

Via Business Wire

Government Relations and Policy Professional Kimberly Pinter Joins Bracewell's Policy Resolution Group in Washington, DC

December 08, 2025

Washington, D.C.--(Newsfile Corp. - December 8, 2025) - Bracewell LLP announced today that Kimberly J. Pinter has joined the firm's...

Via Newsfile

HYMPAVZI® (marstacimab) Reduced Bleeds by 93% Compared to On-Demand Treatment in Adults and Adolescents with Hemophilia A or B with Inhibitors

December 06, 2025

From Pfizer Inc.

Via Business Wire

A Tale Told Through a Bird’s Eyes: Jessica Mann’s Uplift Reimagines How We See the Natural World

December 02, 2025

Via AB Newswire

Topics Bonds

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

December 02, 2025

Via Investor Brand Network

Topics Government

Pfizer Invites Public to View and Listen to Webcast of December 16 Conference Call with Analysts to Provide Full-Year 2026 Financial Guidance

December 01, 2025

From Pfizer Inc.

Via Business Wire

Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now

December 02, 2025

From BioMedWire

Via GlobeNewswire

BioMark Diagnostics Collaborative Lung Cancer Screening Project Honored by ADRIQ during the 35th Innovation Awards Gala

December 01, 2025

Vancouver, British Columbia--(Newsfile Corp. - December 1, 2025) - BioMark Diagnostics Inc. (CSE: BUX) (FSE: 20B) (OTCQB: BMKDF) ("BioMark"), a...

Via Newsfile

Topics Artificial Intelligence

Arvinas Announces Data Presentations from the Vepdegestrant (ARV-471) Clinical Development Program at the 2025 San Antonio Breast Cancer Symposium (SABCS)

November 24, 2025

From Arvinas Inc.

Via GlobeNewswire

U.S. FDA Approves PADCEV® plus Keytruda® for Certain Patients with Bladder Cancer

November 21, 2025

From Pfizer Inc.

Via Business Wire

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For

November 20, 2025

From BioMedWire

Via GlobeNewswire

Pfizer Completes Acquisition of Metsera

November 13, 2025

From Pfizer Inc.

Via Business Wire

Pfizer Invites Public to View and Listen to Webcast of Pfizer Discussion at Healthcare Conference

November 12, 2025

From Pfizer Inc.

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

39 40 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.